Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

World's first human mini-brain with a fully functional blood-brain barrier developed

In a pioneering achievement, a research team led by experts at Cincinnati Children's have developed the world's first human mini-brain that incorporates a fully functional blood-brain barrier (BBB).

20 May 2024

Mediterranean diet can reduce symptoms of stress and anxiety, study shows

It’s no secret that the Mediterranean diet is good for your health. Already recommended to reduce the risks of bowel cancer, heart disease, and dementia, new research from the University of South Australia shows that the Mediterranean diet can also reduce symptoms of stress and anxiety.

20 May 2024

Dentist explains the connection between Alzheimer's and oral health

This week is Dementia Action Week, an event across the UK that aims to get the public to take action to help improve the lives of those living with dementia.

20 May 2024

Study confirms strong barrier preventing chronic wasting disease transmission to humans

A new study of prion diseases, using a human cerebral organoid model, suggests there is a substantial species barrier preventing transmission of chronic wasting disease (CWD) from cervids-;deer, elk and moose-;to people.

17 May 2024

Denmark study: Air pollution tied to increased risk of dementia

This is the first study in Denmark showing a link between air pollution and dementia.

17 May 2024

Twendee X shows promise in reducing oxidative stress in systemic sclerosis

Autoimmune diseases occur when the body's immune system attacks healthy cells instead of protecting them.

17 May 2024

Boosting mitochondrial health can reverse protein clumping in aging and Alzheimer's

It has long been known that a hallmark of Alzheimer's disease, and most other neurodegenerative diseases, is the clumping together of insoluble protein aggregates in the brain.

16 May 2024

Novel gene-delivery vehicle shows promise for treating brain disorders

In an important step toward more effective gene therapies for brain diseases, researchers from the Broad Institute of MIT and Harvard have engineered a gene-delivery vehicle that uses a human protein to efficiently cross the blood-brain barrier and deliver a disease-relevant gene to the brain in mice expressing the human protein.

16 May 2024

Genes and age reveal new insights into cognitive variability, study finds

Study examines the effects of specific genes and age on cognition, revealing potential for creating genotype- and cognition-stratified cohorts for future research.

16 May 2024

Climate change may negatively affect the health of people with brain conditions

Climate change, and its effects on weather patterns and adverse weather events, is likely to negatively affect the health of people with brain conditions, argue a UCL-led team of researchers.

16 May 2024

$Blood pressure medications associated with higher fracture risk among nursing home residents$

Blood pressure medications associated with higher fracture risk among nursing home residents

Records from nearly 30,000 nursing home residents indicate that blood pressure medications more than double the risk of life-threatening bone fractures, according to Rutgers Health research.

16 May 2024

New therapy shows greater weight loss in mice by targeting brain's appetite center

A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications.

16 May 2024

Repurposing human-approved drugs for prion disease treatment

Prions are the abnormal, pathogenic agents that are transmissible and are able to induce abnormal folding of specific normal cellular proteins.

16 May 2024

Unraveling the mystery of Alzheimer's resilience at molecular level

Everyone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process.

16 May 2024

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

From Closed Loop Medicine 16 May 2024

Innovative group training tool for dementia prevention

Solving a quiz as a group while moving around the room at the same time - this combination is the basis of a new tool designed to prevent dementia.

15 May 2024

Study identifies a new biomarker for Alzheimer's disease in asymptomatic stages

A recent study led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona has identified a new biomarker for Alzheimer's disease in asymptomatic stages of the disease.

15 May 2024

Study reveals CNTN4 gene's role in neuronal development and Alzheimer's disease pathogenesis

New research has shed light on the complex interplay between cell proteins, and how they impact on neurons in neurodevelopmental disorders and Alzheimer's disease.

15 May 2024

More than 20,000 volunteers join effort to accelerate dementia drug development

More than 20,000 volunteers have been recruited to a resource aimed at speeding up the development of much-needed dementia drugs. The cohort will enable scientists in universities and industry to involve healthy individuals in clinical trials to test whether new drugs can slow the decline in various brain functions including memory and delay the onset of dementia.

15 May 2024